Marker Therapeutics Balance Sheet Health
Financial Health criteria checks 5/6
Marker Therapeutics has a total shareholder equity of $7.4M and total debt of $0.0, which brings its debt-to-equity ratio to 0%. Its total assets and total liabilities are $10.9M and $3.5M respectively.
Key information
0%
Debt to equity ratio
US$0
Debt
| Interest coverage ratio | n/a |
| Cash | US$9.00m |
| Equity | US$7.45m |
| Total liabilities | US$3.46m |
| Total assets | US$10.91m |
Recent financial health updates
No updates
Recent updates
Financial Position Analysis
Short Term Liabilities: GX1's short term assets ($10.9M) exceed its short term liabilities ($3.5M).
Long Term Liabilities: GX1 has no long term liabilities.
Debt to Equity History and Analysis
Debt Level: GX1 is debt free.
Reducing Debt: GX1 had no debt 5 years ago.
Balance Sheet
Cash Runway Analysis
For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.
Stable Cash Runway: GX1 has sufficient cash runway for more than a year based on its current free cash flow.
Forecast Cash Runway: GX1 has less than a year of cash runway if free cash flow continues to grow at historical rates of 0.4% each year.